Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Genitourinary 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Neoplasm Metastasis 8Esophageal Neoplasms 8Carcinoma, Hepatocellular 7Melanoma 6Lung Neoplasms 6Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Recurrence 2Rectal Neoplasms 2Pathologic Complete Response 2Nasopharyngeal Carcinoma 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Breast Neoplasms, Male 2Turcot syndrome 1Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Radiation Injuries 1Prostatic Neoplasms 1Pleural Mesothelial Neoplasm 1

Interventions

Fluorouracil 9Oxaliplatin 7Leucovorin 7Surveys and Questionnaires 6Blood Specimen Collection 6Bevacizumab 6Specimen Handling 5Gemcitabine 5Cetuximab 5Capecitabine 5fludarabine 4aldesleukin 4Standard of Care 4Irinotecan 4Cyclophosphamide 4Remote Patient Monitoring 3Radiosurgery 3Pafolacianine 3Nivolumab 3Endoscopic Mucosal Resection 3Cisplatin 3130-nm albumin-bound paclitaxel 3encorafenib 2Tomography, X-Ray Computed 2Sunitinib 2Referral and Consultation 2Radiotherapy 2Practice Guidelines as Topic 2Pemetrexed 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Immunotherapy × 1 year × Clear all
NCT05863052 2026-02-10

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

University of Oklahoma

Active not recruiting
72 enrolled
DermatologicGastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis

NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

China Medical University, China

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Hyperthermia, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡